Skip to content

Clinical trials

Completed Autistic Disorder trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autistic Disorder Phase: Not applicable Status: Completed Clear all

274 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20033
20042
20054
20068
20074
20086
200912
20107
20116
20128
201314
201417
201520
201613
201712
201810
201913
202012
202118
202219
202318
202426
202510
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed274

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of California, Los Angeles10
Yale University9
Stanford University8
Massachusetts General Hospital6
Riphah International University6
Karolinska Institutet5
Vanderbilt University Medical Center5
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.4
Icahn School of Medicine at Mount Sinai4
Medical University of South Carolina4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autistic Disorder274
Autism Spectrum Disorder141
Anxiety Disorders20
Child Development Disorders, Pervasive20
Asperger Syndrome17
Attention Deficit Disorder with Hyperactivity10
Developmental Disabilities10
Mental Disorders7
Intellectual Disability5
Anxiety, Separation4

Trials

Showing 1 to 25 of 274. Each trial links to its page on Pharma Observatory.

174 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.